Contents
In the Comprehensive Health Services Air Force unapproved drugs settlement, the company agreed to pay $930,000 over allegations involving drug approvals and patient-record security. The supply allegation concerned controlled substances delivered to patients under Air Force and State Department contracts. For someone who knew the purchasing, pharmacy or billing work, the question was concrete: did the drugs supplied carry the approval the company promised?
The Justice Department announced the combined civil settlement on March 8, 2022. CHS, a global healthcare contractor based in Cape Canaveral, Florida, provided medical support at government-run facilities in Iraq and Afghanistan. The settlement covered two whistleblower cases, including one against CHS Middle East. The patient-record allegation concerned a State Department contract.
The Air Force and State Department contracts required CHS to supply medical products, including controlled substances, approved by the U.S. Food and Drug Administration or the European Medicines Agency and manufactured under federal quality standards. The government alleged that CHS falsely represented certain substances as approved between 2012 and 2019. That is the nonconforming defense-product allegation at the center of this case: the approval promised to the customer and the product supplied did not match, according to the government.
The State Department contract filed with the whistleblowers’ complaint shows how directly the purchasing responsibility sat with the contractor. Its medical-supplies provision assigned CHS responsibility for supply-chain management, including determining which pharmaceuticals, supplies and equipment patient care required:
The Contractor shall find their own sources for material ordered
The contractor also had to ensure that products used in patient care had approval from the U.S. Food and Drug Administration or the European Medicines Agency. The same provision made the Defense Department supply chain a backup and placed cross-border documentation on the contractor. We see a straightforward bargain here: choose the supplier, keep the promised standard. The government was buying the contractor’s ability to source approved supplies, all the way through to their use in health care.
According to the Justice Department’s account, CHS lacked the DEA license needed to export controlled substances from the United States to Iraq. The government described an alternative route involving CHS physicians in Florida, a physician in South Africa and a South African shipping company.
The government said CHS physicians in Florida sent letters asking the South African physician to prescribe controlled substances. The shipping company then received substances that the government said lacked the required approval and sent them to CHS in Iraq. CHS allegedly supplied those substances to patients under both the State Department and Air Force contracts. We see a long route around a simple promise: approved drugs for the patients. All that distance, the same obligation.
The electronic-medical-record allegation concerned CHS’s State Department work. The Justice Department called this its first resolution of a False Claims Act cyber-fraud case since launching its Civil Cyber-Fraud Initiative.
According to the government, CHS submitted claims to the State Department for a secure system to store patient records, including confidential identifying information about service members, diplomats, officials and contractors receiving care in Iraq. The government alleged that, between 2012 and 2019, CHS failed to disclose that it had not consistently stored those records securely.
The alleged problem arose during scanning. The government alleged that staff left scanned copies of some patient records on an internal network drive accessible to nonclinical employees and that CHS did not adequately correct the practice after staff raised privacy concerns. That puts the cybersecurity representation alongside an everyday workflow: where the scanned copy stayed, who could reach it and what happened after someone objected. The State Department contract also required patient-record confidentiality and made the medical records government property.
The civil settlement resolved two cases brought under the False Claims Act’s whistleblower provisions. One named CHS Middle East, and the other named Comprehensive Health Services. The CHS Middle East case included whistleblowers with medical, nursing and pharmacy qualifications.
The investigation involved the State Department Office of Inspector General and the Air Force Office of Special Investigations. The question connecting the allegations was what CHS told the government it was providing.
A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers. In a medical-supply matter, we build the whistleblower case around the relationship between the promised approval, the supplied product and the government’s bill.
The State Department contract’s invoice provisions required products or services delivered to appear by line item, tied to the corresponding task order or contract. Each line needed a description, quantity, unit price, total, delivery date and contract line-item number. That gave the supply story a place in the bill: what the contractor said it delivered, when and under which obligation.
The payment terms also distinguished fixed-price work from reimbursed costs. Fixed-price invoices could cover supplies and services delivered during the month. For cost-reimbursement items, the contractor had to list purchases and unit costs and provide supporting purchase documentation as applicable.
For the Air Force supplies allegation, we would connect the promised approval to the substances delivered under the Air Force contract and the associated payment records. Purchasing and shipping employees may know the source chosen and the route used. A clinician may know what reached the clinic, while a billing employee may hold the connection to the government charge. Together, those accounts can give substance to a representation that looks unremarkable on an invoice.
The same approach keeps the patient-record issue tied to the money. The government said CHS charged for secure electronic storage while leaving scanned copies accessible elsewhere. Someone familiar with that workflow or the concerns raised about it may understand the gap between the service billed and the practice inside the operation.
If you know the drugs ordered, the approvals claimed or the bills submitted for overseas medical care, speak with our whistleblower experts about the drugs that reached the clinic. We work with you to connect that knowledge to the government’s contract and bring in defense contractor fraud whistleblower lawyers who understand medical-supply obligations. We stay beside you throughout the process to build your strongest defense contractor whistleblower case.